Juliana Hansen, M.D., says the growing trend of labiapasty procedures could indicate a possible increase in awareness and conversation about vaginal health when “for many generations, vaginal health has been considered taboo and procedures and option for care for female genitalia weren’t available.”

Nancy Durben, P.T., is announced as the National Hemophilia Foundation’s 2020 Physical Therapy Excellence Fellowship recipient.

An artificial intelligence algorithm developed by OHSU and Massachusetts General Hospital to diagnose and help treat retinopathy of prematurity has been granted breakthrough status by the FDA.

In a set of recommendations to manage digital innovations in monitoring cognitive decline, Walt Dawson, Ph.D., says, “The population of people living with illnesses affecting brain health is increasing rapidly around the world. The burden of dementia will be disproportionately experienced in low- and middle-income countries.”

A news release about the upcoming South Texas Alzheimer’s Conference highlights Jeff Kaye, M.D., who will speak about technology advancing assessments and interventions for dementia.

While discussing how pharmacists can help pharmacy clients presenting with cold symptoms, Donald Backus, Pharm.D., says “We should keep track of what they’re presenting with symptom-wise and make sure it’s not something more serious.”

Todd Korthuis, M.D., is quoted in a story about a new telehealth app to improve care for substance use disorder in underserved rural areas. “It’s the wild west out there. The technology hasn’t been fully vetted yet and everyone is scrambling for market share,” he says.

Dawn Nolt, M.D. is quoted as saying OHSU would use well-established infectious disease control measures should OHSU treat a patient with the novel coronavirus.

A report completed by the Center for Health Systems Effectiveness is referenced in this editorial about a 2020 senate bill that would establish a new dental therapist role to expand care access to Oregonians.

Several studies led by Vinay Prasad, M.D., M.P.H., are cited in a story examining the “hype vs. reality” in the cancer industry.